GM-CSF promotes migration of human monocytes across the blood brain barrier. 2015

Daphne Y S Vogel, and Gijs Kooij, and Priscilla D A M Heijnen, and Marjolein Breur, and Laura A N Peferoen, and Paul van der Valk, and Helga E de Vries, and Sandra Amor, and Christine D Dijkstra
Department of Molecular Cell Biology and Immunology, VU University Medical Center Amsterdam, Neuroscience Campus, Amsterdam, The Netherlands.

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS). Infiltration of monocytes into the CNS is crucial for disease onset and progression. Animal studies indicate that granulocyte-macrophages colony-stimulating factor (GM-CSF) may play an essential role in this process, possibly by acting on the migratory capacities of myeloid cells across the blood-brain barrier. This study describes the effect of GM-CSF on human monocytes, macrophages, and microglia. Furthermore, the expression of GM-CSF and its receptor was investigated in the CNS under healthy and pathological conditions. We show that GM-CSF enhances monocyte migration across human blood-brain barrier endothelial cells in vitro. Next, immunohistochemical analysis on human brain tissues revealed that GM-CSF is highly expressed by microglia and macrophages in MS lesions. The GM-CSF receptor is expressed by neurons in the rim of combined gray/white matter lesions and astrocytes. Finally, the effect of GM-CSF on human macrophages was determined, revealing an intermediate activation status, with a phenotype similar to that observed in active MS lesions. Together our data indicate that GM-CSF is a powerful stimulator of monocyte migration, and is abundantly present in the inflamed CNS where it may act as an activator of macrophages and microglia.

UI MeSH Term Description Entries
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females

Related Publications

Daphne Y S Vogel, and Gijs Kooij, and Priscilla D A M Heijnen, and Marjolein Breur, and Laura A N Peferoen, and Paul van der Valk, and Helga E de Vries, and Sandra Amor, and Christine D Dijkstra
August 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Daphne Y S Vogel, and Gijs Kooij, and Priscilla D A M Heijnen, and Marjolein Breur, and Laura A N Peferoen, and Paul van der Valk, and Helga E de Vries, and Sandra Amor, and Christine D Dijkstra
October 2017, Immunology and cell biology,
Daphne Y S Vogel, and Gijs Kooij, and Priscilla D A M Heijnen, and Marjolein Breur, and Laura A N Peferoen, and Paul van der Valk, and Helga E de Vries, and Sandra Amor, and Christine D Dijkstra
September 2007, Physiology & behavior,
Daphne Y S Vogel, and Gijs Kooij, and Priscilla D A M Heijnen, and Marjolein Breur, and Laura A N Peferoen, and Paul van der Valk, and Helga E de Vries, and Sandra Amor, and Christine D Dijkstra
April 1986, Developmental medicine and child neurology,
Daphne Y S Vogel, and Gijs Kooij, and Priscilla D A M Heijnen, and Marjolein Breur, and Laura A N Peferoen, and Paul van der Valk, and Helga E de Vries, and Sandra Amor, and Christine D Dijkstra
August 1985, Developmental medicine and child neurology,
Daphne Y S Vogel, and Gijs Kooij, and Priscilla D A M Heijnen, and Marjolein Breur, and Laura A N Peferoen, and Paul van der Valk, and Helga E de Vries, and Sandra Amor, and Christine D Dijkstra
March 1990, Journal of leukocyte biology,
Daphne Y S Vogel, and Gijs Kooij, and Priscilla D A M Heijnen, and Marjolein Breur, and Laura A N Peferoen, and Paul van der Valk, and Helga E de Vries, and Sandra Amor, and Christine D Dijkstra
November 2001, International immunopharmacology,
Daphne Y S Vogel, and Gijs Kooij, and Priscilla D A M Heijnen, and Marjolein Breur, and Laura A N Peferoen, and Paul van der Valk, and Helga E de Vries, and Sandra Amor, and Christine D Dijkstra
January 1997, Hematology (Amsterdam, Netherlands),
Daphne Y S Vogel, and Gijs Kooij, and Priscilla D A M Heijnen, and Marjolein Breur, and Laura A N Peferoen, and Paul van der Valk, and Helga E de Vries, and Sandra Amor, and Christine D Dijkstra
January 1992, Nouvelle revue francaise d'hematologie,
Daphne Y S Vogel, and Gijs Kooij, and Priscilla D A M Heijnen, and Marjolein Breur, and Laura A N Peferoen, and Paul van der Valk, and Helga E de Vries, and Sandra Amor, and Christine D Dijkstra
November 2011, Journal of neuroinflammation,
Copied contents to your clipboard!